Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Bristol Myers Squibb (BMY) will participate in investor conferences in May 2024. Ben Hickey and David Elkins will engage in fireside chats at separate events, addressing questions about the company. Both sessions are open to investors and the public via the company's investor website.
- None.
- None.
Ben Hickey, President, RayzeBio, Head of Mirati, will take part in a fireside chat at the Guggenheim Healthcare Talks Radiopharmaceuticals Day on Monday, May 13, 2024. He will answer questions about the company beginning at 11:00 a.m. ET.
David Elkins, Executive Vice President, Chief Financial Officer, will participate in a fireside chat at the 2024 Bank of America Global Healthcare Conference on Wednesday, May 15, 2024. He will answer questions about the company beginning at 11:20 a.m. PT/2:20 p.m. ET.
Investors and the general public are invited to listen to both sessions at their respective times by visiting http://investor.bms.com. An archived edition of each session will be available following its conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20240507673830/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When will Bristol Myers Squibb participate in investor conferences in May 2024?
Who will take part in the fireside chat at the Guggenheim Healthcare Talks Radiopharmaceuticals Day?
Who will participate in the fireside chat at the 2024 Bank of America Global Healthcare Conference?
How can investors and the general public listen to the sessions?
